News & media


Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Therefore, a thorough understanding of these response patterns and the new criteria used to assess them is critical for conducting a successful clinical trial for immunotherapy. Today, a Read more

Cookies help us deliver our services. By using our services, you agree to our use of cookies.